Glenmark Gets CDSCO panel nod to market asthma, COPD drug Dr. Divya Colin14 Jun 2022 6:30 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization...
CDSCO panel approves Allergan Dexamethasone Intravitreal Implant for Diabetic Macular Edema Dr. Divya Colin13 Jun 2022 6:00 PM ISTNew Delhi: Based on the justification provided by the drug-maker Allergan India, the Subject Expert Committee (SEC) functional under Central Drug...
AstraZeneca gets CDSCO panel nod to study anticancer drug Durvalumab Dr. Divya Colin3 Jun 2022 7:00 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got the go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
CDSCO panel tells Abbott to present more data on Metronidazole Extended Release Tablet Dr. Divya Colin29 May 2022 2:13 PM ISTNew Delhi: Denying the pharmaceutical major Abbott Healthcare proposal to manufacture and market antibiotic Metronidazole Extended Release Tablet for...
There is no unmet need: CDSCO Panel rejects J&J proposal to Import and manufacture Paliperidone Palmitate Dr. Divya Colin29 May 2022 11:29 AM ISTNew Delhi: Citing that there is no unmet need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Include more sites from govt hospitals: CDSCO panel tells Intas on Tofacitinib Ointment 2% CT study Dr. Divya Colin15 May 2022 12:30 PM ISTNew Delhi: Directing the pharma major Intas Pharma to include more study sites from government hospitals geographically distributed in the country,...
Glenmark gets CDSCO panel nod to manufacture and market COPD drug Dr. Divya Colin9 May 2022 6:52 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical major Glenmark pharmaceuticals, the Subject Expert Committee (SEC) of the Central...
Dr. Reddy's gets CDSCO panel nod to study Fosravuconazole L Lysine Ethanolate Capsule Dr. Divya Colin25 April 2022 8:06 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Setback: AstraZeneca proposal to market, manufacture Olaparib rejected by CDSCO panel Dr. Divya Colin23 April 2022 5:03 PM ISTNew Delhi: In a major setback to AstraZeneca, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
Mylan gets CDSCO nod to import and market Liposomal Amphotericin B Injection Dr. Divya Colin8 April 2022 6:23 PM ISTNew Delhi: Pharmaceutical major, Mylan Pharmaceuticals has got the go ahead from the Subject Expert Committee ( SEC) of the Central Drugs Standard...
NovoNordisk gets CDSCO panel okay to study anti-diabetic drug Semaglutide Dr. Divya Colin5 April 2022 5:56 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's justification for anti-diabetic drug Semaglutide the Subject Expert Committee (SEC) of the...
Sanofi Gets CDSCO panel okay for retrospective study of Insulin Glargine Dr. Divya Colin2 April 2022 6:05 PM ISTNew Delhi: Pharmaceutical major, Sanofi has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
